Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
on page 1 showing 20 out of 758 results from 1 sources
https://web.expasy.org/cellosaurus/CVCL_0002

Cite this: (JCRB Cat# IFO50022, RRID:CVCL_0002)
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: IIL-60; Occasionally. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0006

Cite this: (CLS Cat# 300356/p804_THP-1, RRID:CVCL_0006)
Organism: Homo sapiens
Disease: Childhood acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: MD Anderson Cell Lines Project. Part of: RAS genetic alteration cell panel (ATCC TCP-1031). Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA. Doubling time: 60-70 hours (PubMed=6970727); 26 hours (PubMed=25984343); ~35-50 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Asp (ATCC); p.Gly12Ser according to PubMed=9379676. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep promoter analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Glycoproteome analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0031

Cite this: (NCBI_Iran Cat# C135, RRID:CVCL_0031)
Organism: Homo sapiens
Disease: Invasive ductal carcinoma, not otherwise specified
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: JFCR45 cancer cell line panel. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Registration: Chiron Master Culture Collection; CMCC 10377 (CMCC #10377). Doubling time: 1.8 days (PubMed=9671407); 80 hours (PubMed=25984343); 31.2 hours (PubMed=22628656); 25.4 hours (NCI-DTP); ~50 hours, with a range of 30-72 hours (DSMZ); ~38 hours (PBCF). Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=23671654; Sanger). Sequence variation: Heterozygous for PIK3CA p.Glu545Lys (PubMed=17088437; PubMed=28889351). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: miRNA expression profiling. Omics: Myristoylated proteins analysis by proteomics. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Anecdotal: This is the first hormone-responsive breast cancer cell line to have been established. Anecdotal: Helen Mallon (sister Catherine Frances), the patient from which this cell line is derived was a nun (Sister Catherine Frances) at the Immaculate Heart of Mary Convent in Monroe, Michigan. Misspelling: MFC-7; Occasionally. Discontinued: ATCC; CRL-12584. Discontinued: JCRB; NIHS0200. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0186

Cite this: (DSMZ Cat# ACC-760, RRID:CVCL_0186)
Organism: Homo sapiens
Disease: Pancreatic ductal adenocarcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Doubling time: 48-60 hours (PubMed=3754176); 48 hours (PubMed=25984343); ~48 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Homozygous for a CDKN2A deletion (PubMed=11169959). Sequence variation: Has no KRAS mutation (PubMed=8026879; PubMed=11115575). Sequence variation: TP53 p.Tyr220Cys (PubMed=8026879; PubMed=11115575). Omics: Transcriptome analysis. Omics: Array-based CGH. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0527

Cite this: (KCLB Cat# 30070, RRID:CVCL_0527)
Organism: Homo sapiens
Disease: Cutaneous melanoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-522. Doubling time: 70 hours (PubMed=25984343); 25.2 hours (NCI-DTP). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for BRAF p.Val600Glu (c.1799T>A) (PubMed=17088437; PubMed=24576830). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from metastatic site: Axillary lymph node.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_1045

Cite this: (DSMZ Cat# ACC-438, RRID:CVCL_1045)
Organism: Homo sapiens
Disease: Prostate carcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Doubling time: ~49 hours (PubMed=10462204); 55 hours (PubMed=25984343); 63 hours (from cell counting), 94 hours (from absorbance) (DOI=10.5897/IJBMBR2013.0154); 40 hours (ATCC); 40-60 hours (DSMZ); ~41 hours (PBCF). Microsatellite instability: Instable (MSI-high) (PubMed=23671654; Sanger). Omics: Array-based CGH. Omics: Deep exome analysis. Omics: DNA methylation analysis. Omics: Deep RNAseq analysis. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_1103

Cite this: (DSMZ Cat# ACC-255, RRID:CVCL_1103)
Organism: Homo sapiens
Disease: Ewing sarcoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Doubling time: 48 hours (PubMed=25984343); ~35 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Omics: Deep exome analysis. Omics: DNA methylation analysis. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_1644

Cite this: (ATCC Cat# CRM-CRL-3211, RRID:CVCL_1644)
Organism: Homo sapiens
Disease: Pancreatic adenocarcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Characteristics: Established from a frozen tumor that had been stored at -80 Celsius for 1.5 years and which has then been passaged into a nude mice. Doubling time: 21 hours (PubMed=3778442); 35 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for KRAS p.Gly12Arg (PubMed=3778442). Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_1709

Cite this: (KCLB Cat# 0000C2A, RRID:CVCL_1709)
Organism: Homo sapiens
Disease: Cecum adenocarcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: Seoul National University (SNU) cell line collection. Doubling time: 50 hours (PubMed=25984343). Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053). Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: SUN-C2A; Occasionally.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_3003

Cite this: (JCRB Cat# JCRB0177.1, RRID:CVCL_3003)
Organism: Homo sapiens
Disease: Pancreatic ductal adenocarcinoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated. Parent cell line (KP-1N) has been shown to be a PANC-1 derivative. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Doubling time: 25 hours (PubMed=25984343). Sequence variation: KRAS p.Gly12Asp (from parent cell line). Sequence variation: TP53 p.Arg273His (from parent cell line). Sequence variation: Homozygous for a CDKN2A deletion (from parent cell line). Omics: shRNA library screening. Discontinued: JCRB; NIHS0274.1.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_3959

Cite this: (RRID:CVCL_3959)
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Doubling time: 24 hours (PubMed=25984343). Sequence variation: TP53 p.Val173Met and p.Arg282Trp (PubMed=7732013; PubMed=10416987). Omics: shRNA library screening.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_IW56

Cite this: (RRID:CVCL_IW56)
Organism: Homo sapiens
Disease:
Category: Transformed cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Doubling time: 48 hours (PubMed=25984343). Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0002

Cite this: (BCRC Cat# 60027, RRID:CVCL_0002)
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: IIL-60; Occasionally. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0002

Cite this: (IZSLER Cat# BS TCL 25, RRID:CVCL_0002)
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: IIL-60; Occasionally. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0002

Cite this: (ICLC Cat# HTL95010, RRID:CVCL_0002)
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: IIL-60; Occasionally. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0002

Cite this: (KCB Cat# KCB 2014051YJ, RRID:CVCL_0002)
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: IIL-60; Occasionally. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0002

Cite this: (DSMZ Cat# ACC-3, RRID:CVCL_0002)
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: IIL-60; Occasionally. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0002

Cite this: (TKG Cat# TKG 0345, RRID:CVCL_0002)
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: IIL-60; Occasionally. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0002

Cite this: (BCRJ Cat# 0104, RRID:CVCL_0002)
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: IIL-60; Occasionally. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0002

Cite this: (ATCC Cat# CCL-240, RRID:CVCL_0002)
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: IIL-60; Occasionally. Derived from sampling site: Peripheral blood.

  • From Current Category

  1. Resource Identification Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Save Your Search

    You can save any searches you perform for quick access to later from here.

  6. Query Expansion

    We recognized your search term and included synonyms and inferred terms along side your term to help get the data you are looking for.

  7. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  8. Sources

    Here are the sources that were queried against in your search that you can investigate further.

  9. Categories

    Here are the categories present within RRID that you can filter your data on

  10. Subcategories

    Here are the subcategories present within this category that you can filter your data on

  11. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

X